Want to see IL:NRGN full AI Analyst Report?
NRGN Stock Chart & Stats
139.30
0.03(0.96%)
At close: 4:00 PM EST
139.30
0.03(0.96%)
Day’s Range― - ―
52-Week Range65.00 - 305.90
Previous CloseN/A
Volume1.26K
Average Volume (3M)6.88K
Market Cap
₪8.93M
Enterprise Value5.76T
Total Cash (Recent Filing)₪3.18M
Total Debt (Recent Filing)₪145.02K
Price to Earnings (P/E)―
Beta0.64
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,327,785
10 Day Avg. Volume4,430
30 Day Avg. Volume6,880
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)1.94
Price to Sales (P/S)2.64
P/FCF Ratio116.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Gross Margin ReboundThe sharp 2025 revenue rebound and substantial gross-margin improvement indicate stronger commercial traction and better economics for the software and services model. If retained, these gains could provide a stronger base for scaling the platform and moving toward sustainable profitability.
Improved Operating Cash FlowThe shift from several years of heavy cash burn to positive operating cash flow is an important operational improvement. It suggests the business is currently funding more of its activities internally, although the small free-cash-flow surplus still needs to become more consistent.
Conservative LeverageVery low debt relative to equity limits interest and refinancing pressure and gives NRGene more financial flexibility than a highly leveraged software business. This balance-sheet position can help the company absorb volatility and support investment while it works to improve profitability.
Bears Say
Persistent Operating LossesDespite the revenue and gross-margin rebound, NRGene remains deeply loss-making at both the net and operating levels. Continued negative margins weaken internal funding capacity, delay the path to durable earnings, and leave the company reliant on further growth or cost improvements.
Unproven Free Cash Flow DurabilityPositive free cash flow is currently too modest and volatile to demonstrate a durable cash-generating model. The sharp year-over-year decline and limited conversion relative to losses suggest that NRGene may not yet have dependable resources to fund expansion, absorb setbacks, or reduce reliance on capital.
Historical Equity And Return PressureNegative shareholder returns show that the company is not yet producing value from its equity base, while the prior period of negative equity highlights historical financial strain. Continued losses could erode capital again over time and reduce flexibility for funding the business.
NRGN FAQ
What was NRGENE TECHNOLOGIES LTD’s price range in the past 12 months?
NRGENE TECHNOLOGIES LTD lowest stock price was 65.00 and its highest was 305.90 in the past 12 months.
What is NRGENE TECHNOLOGIES LTD’s market cap?
NRGENE TECHNOLOGIES LTD’s market cap is ₪8.93M.
When is NRGENE TECHNOLOGIES LTD’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NRGENE TECHNOLOGIES LTD’s earnings last quarter?
Currently, no data Available
Is NRGENE TECHNOLOGIES LTD overvalued?
According to Wall Street analysts NRGENE TECHNOLOGIES LTD’s price is currently Overvalued.
Does NRGENE TECHNOLOGIES LTD pay dividends?
NRGENE TECHNOLOGIES LTD does not currently pay dividends.
What is NRGENE TECHNOLOGIES LTD’s EPS estimate?
NRGENE TECHNOLOGIES LTD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NRGENE TECHNOLOGIES LTD have?
NRGENE TECHNOLOGIES LTD has 13,327,785 shares outstanding.
What happened to NRGENE TECHNOLOGIES LTD’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NRGENE TECHNOLOGIES LTD?
Currently, no hedge funds are holding shares in IL:NRGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NRGENE TECHNOLOGIES LTD
NRGene Technologies Ltd is an AI-powered genomics firm that designs sophisticated computational tools and advanced algorithms, serving clients globally across North America, Europe, the Middle East, Africa, and Asia Pacific. The company provides specialized software applications and complete, ready-to-use solutions for various sectors, including agricultural breeding, food technology, academia, research institutions, and agribiotech enterprises. Additionally, NRGene develops custom genetic panels tailored for a broad range of plants, from staple crops like wheat, canola, corn, soybeans, and maize to cannabis. Established in 2009, its headquarters are located in Ness Ziona, Israel.